Provider of non-surgical treatment option for skin cancer patients
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | SKINCURE ONCOLOGY |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$100,000 | |
| 2025 | SKINCURE ONCOLOGY |
4th Quarter (Oct 1 - Dec 31) AMENDED |
$120,000 | |
| 2025 | SKINCURE ONCOLOGY |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$120,000 | |
| 2025 | SKINCURE ONCOLOGY |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$130,000 | |
| 2025 | SKINCURE ONCOLOGY |
3rd Quarter (July 1 - Sep 30) Registration |
— |
| Firm | Filings | Expenses |
|---|---|---|
| SKINCURE ONCOLOGY | 5 | $350,000 |
| Issue | Activities |
|---|---|
| Medical/Disease Research/Clinical Labs | 5 |
| Medicare/Medicaid | 5 |